Beruflich Dokumente
Kultur Dokumente
in India. These companies were identified based on their relentless TCS IN TCS+ 67,681
improvement in financial performance over long periods (i.e. six years). ITC IN ITC+ 44,009
The first five iterations of our annual ten baggers portfolio have done HCLT IN HCL Technologies+ 17,538
remarkably well with ~24% TSR (on a CAGR basis over the past five GPPV IN Guj Pipavav Port 941
years). The sub-BSE500 ten baggers list too has delivered a whopping BRIT IN Britannia Industries++ 5,060
~45% TSR on a CAGR basis over the last four years. Using FY16 annual PIDI IN Pidilite Industries+ 4,614
reports, we now refresh our annual list of ten baggers. Clients interested TRP IN Torrent Pharma+ 3,380
in accessing our proprietary models can now use our ‘HAWK’ platform to MACA IN Mahindra CIE+ 1,044
screen the entire universe of listed companies (ex-financials) on the
TELX IN Tata Elxsi 657
basis of their accounting and greatness scores.
Moderate valuations**
Our relentless focus on franchises that keep improving HUVR IN Hind. Unilever+ 26,532
In spite of the recent demonetisation-driven disruption (click here), we find that PAG IN Page Industries+ 2,262
structurally strong companies, like the ones we aim to identify through our ten- VTEX IN Vardhman Textile 1,039
bagger portfolios, tend to be all-weather performers. These companies have Rich valuations***
credible management teams that are focused on building cash-generative
EIM IN Eicher Motors++ 8,936
franchises and, hence, remain consistent performers through economic booms
MRCO IN Marico++ 4,947
and busts. Both in live portfolios and back-tests, the approach delivers
MRF IN MRF 3,227
impressive alpha in most years whilst investing in high-quality franchises.
BRGR IN Berger Paints++ 3,057
A back-test of the ‘greatness’ framework has yielded impressive returns
AJP IN Ajanta Pharma 2,317
1,000 AIAE IN AIA Engineering+ 1,796
18.6% CAGR
Greatness PI IN P I Industries+ 1,692
800
model KJC IN Kajaria Ceramics 1,158
600 14.3% CAGR
FNXC IN Finolex Cables+ 936
Source: Ambit Capital research. Note: The back-test is based on annual rebalancing with forward-looking SRTY IN TVS Srichakra 369
returns being calculated from December 31 of year X to December 31 of year X+1; for example, in the AVNT IN Avanti Feeds 340
exhibit above for the most recent year, the framework included numbers until FY15 and returns have been
Source: Ambit Capital research. Note: Mcap as on 05 Jan
calculated from 31 December 2015 to 31 December 2016. 2017.
The ‘greatness’ philosophy works… year after year * Trading below five-year P/E, P/B, EV/EBITDA
(on at least two of these three measures)
Consistent improvements in corporate performance are more important than ** Trading below either five-year P/E, five-year P/B or five-
year EV/EBITDA (on one of these three measures)
’great leaps’ - this has been the guiding philosophy of our ’greatness‘ *** Trading above five-year P/E, P/B, EV/EBITDA
framework, which lies at the core of our process of identifying structurally sound # denotes new entrant to our ten baggers portfolio
+/(++) Indicates that the Ambit sector lead has a bottom-
businesses. Not only do the great firms perform significantly better than an up BUY/(SELL) on the name
average firm various measures, more importantly, they show a more consistent
and calibrated approach to growth over long periods. In this note, we update
our ’greatness‘ framework to include FY16 numbers. The framework uses the
following attributes to measure consistent financial improvements: judicious
capex, conversion of capex to sales, pricing discipline, balance sheet discipline,
Research Analysts
cash generation and net profit improvement, and return ratio improvement.
Karan Khanna, CFA
This year’s portfolio
+91 22 3043 3251
Of the 99 firms from BSE500 that pass more than two-thirds of the tests in our karan.khanna@ambit.co
greatness framework, the best 30 that clear our accounting and corporate
governance filters make it to this year’s list. Of these 30 firms, we have bottom- Nitin Bhasin
up coverage with BUYs on 13 firms (see exhibit on the right). 70% of the stocks +91 22 3043 3241
in this year’s portfolio also featured in last year’s portfolio, implying 30% churn. nitin.bhasin@ambit.co
Ambit Capital and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, investors should be aware that Ambit Capital
may have a conflict of interest that could affect the objectivity of this report. Investors should not consider this report as the only factor in making their investment decision.
Strategy
CONTENTS
c. Pricing discipline
(PBIT margin) Clearly, this approach will
have limited value if there is a
structural break in the sector
or in the company, which
makes past performance a
e. Cash generation d. Balance sheet meaningless guide to future
discipline (D/E, cash performance. (For identifying
(CFO)
structural breaks of this sort,
ratio)
for example in the Indian
boiler-turbine-generator
Source: Ambit Capital research sector or in the Indian utilities
sector, we look to our sector
We rank the BSE500 universe of firms (excluding financial services firms and leads for help.)
excluding firms with insufficient data) on our ’greatness‘ score, which consists of six
equally weighted headings—investments, conversion to sales, pricing discipline,
However, to the extent that
balance sheet discipline, cash generation and EPS improvement, and return ratio
such structural breaks tend to
improvement. be the exception than the
Under each of these six headings, we further look at two kinds of improvements: rule, the greatness model
helps in creating a shortlist of
Percentage improvements in performance over FY14-16 vs FY11-13; and stocks that investors can then
analyse in greater detail.
Consistency in performance over FY11-16; i.e. improvements adjusted for
underlying volatility in financial data Put simply, the greatness
model separates the wheat
A complete list of factors that are considered whilst quantifying greatness has been from the chaff. Yet, it does not
provided in Exhibit 2 on the next page. cook the whole meal for you!
We rank the BSE500 universe of firms (excluding financial services firms) on this score
to arrive at this year’s rankings on this measure of structural strength. After removing
financial services firms and firms with insufficient data, 411 firms from the BSE500
were ranked based on this measure. The highlights from the distribution of these
firms on our ’greatness‘ score are displayed on the next page.
On page 6, we show a back-test of this framework over FY04-2016 and find that it
works on a consistent basis. On pages 15-17, we show the real world performance of
these sets of portfolios over the last year and demonstrate that the construct works in
the real world as well. On a total shareholder returns basis (i.e. assuming dividends
are reinvested into the same stock on the ex-dividend date), the lists from the BSE500
universe have cumulatively delivered ~24% total CAGR returns (over the past four
years) vs 14% total CAGR returns for the BSE500 Index. Similarly, the lists from the
sub-BSE500 universe that we had published in our previous four iterations have
cumulatively delivered ~45% total CAGR returns (over the past four years) vs ~14%
CAGR returns for the BSE Small-cap Index.
On pages 8-12, we delve into this year’s list of 30 firms that constitute our ten
baggers 6.0. This is followed by a list of 11 firms from the sub-BSE500 universe that
do well on the same framework.
Quantifying greatness
From the universe of BSE500 firms, after removing financial services firms and firms *The greatness score is
with insufficient data, 411 firms were scored on the six headings highlighted on the
calculated by assigning
previous page. The cut-off for greatness was placed at 67%* and only 99 firms (24%
equal weightages to the six
of the total population of 411 firms) could manage a score above this cut-off.
factors outlined in Exhibit 2
Exhibit 3: Distribution of firms on the greatness score (total population: 411 firms) on page 4.
90.0 Zone of mediocrity Good, not great Zone of 'greatness'
80.0 Thus, each of these six
224 firms score 88 firms Only 99 firms score
factors carries a weightage
No. of firms
20%-30%
30%-40%
40%-50%
50%-60%
60%-70%
70%-80%
80%-90%
0%-10%
90%-100%
These scores are then
cumulated to arrive at a
Source: Ambit Capital research
final greatness score on 100
In the next exhibit, we present key financial data on the three zones defined above: for the firm.
Mediocrity (224 firms), Good but not great (88 firms), and Great (99 firms).
Exhibit 4: Zones of greatness - Financial summary
Good but not
Mediocre Great
great
Number of firms 224 88 99
Mcap (US$ mn)* 669 809 1,053
Share price (3-year CAGR)# 18% 25% 43%
Gross block (3-year CAGR) 10% 10% 14%
Sales (3-year CAGR) 6% 12% 15%
Adj PAT (3-year CAGR) 2% 18% 29%
CFO (3-year CAGR) 6% 21% 27%
PBIT Margin (3-year average) 9% 14% 15%
RoE (3-year average) 9% 17% 24%
RoCE (3-year average) 11% 18% 27%
Net debt equity (3-year average) 0.31 0.28 0.07
FY17 P/E 20.7 22.4 22.2
FY17 P/B 2.6 3.4 4.7
FY18 P/E 16.5 18.3 19.7
FY18 P/B 2.3 2.9 3.8
Source: Capitaline, Ambit Capital research; Note: All figures are based on median values of the firms analysed
*Mcap as of 05 January 2017. # indicates share price performance from 03 January 2014 to 05 January 2017.
With regard to fundamentals, the superiority of the great firms compared with the
other two groups is evident in Exhibit 4 above. Of these 99 great firms, we identify
the ones that perform the best on our accounting and corporate governance filters,
and this leads to our final list of 30 great companies. Before we move onto these 30
potential ten baggers, we shall discuss a back-test of the ‘greatness’ framework in the
next section to see whether ‘great’ firms have indeed managed to deliver superior
returns historically.
1,000
Greatness
800
18.6% CAGR model Over 2004-16, ‘Great’ firms have
outperformed the universe by
600 14.3% CAGR 4.4% points per annum (on
Universe
(average average returns) and the BSE500
400 basis) Index by 6.1% points per annum
12.6% CAGR
200 BSE500
-
Jan-04
Jan-05
Jan-06
Jan-07
Jan-08
Jan-09
Jan-10
Jan-11
Jan-12
Jan-13
Jan-14
Jan-15
Jan-16
Jan-17
Source: Ambit Capital research; Note: The back-test is based on annual rebalancing with forward-looking returns
being calculated from December 31 of year X to December 31 of year X+1; for example, in the exhibit above for
the most recent year, the framework included numbers until FY15 and returns have been calculated from 31
December 2015 to 31 December 2016. (Note: The above exhibit only considers the share price returns and not
the total shareholder returns).
Outperformance was also seen on a median basis. A median firm in the universe has
delivered 4.5% CAGR returns (over 2004-2016). In contrast, a median ‘great’ firm
has managed to deliver 8.5% CAGR returns, thus resulting in an outperformance of
~4% (on a CAGR basis) for ‘great’ firms vs the universe.
Exhibit 6: Median performance of ‘Great’ firms vs the Universe (2004-2016)
350
300 Outperformance was also seen
250 8.5% Greatness on a median basis
CAGR model
200
150 Universe
4.5% (median
100 CAGR basis)
50
0
Jan-04
Jan-05
Jan-06
Jan-07
Jan-08
Jan-09
Jan-10
Jan-11
Jan-12
Jan-13
Jan-14
Jan-15
Jan-16
Jan-17
Source: Ambit Capital research; Note: The back-test is based on annual rebalancing with forward-looking returns
being calculated from December 31 of year X to December 31 of year X+1; for example, in the exhibit above for
the most recent year, the framework included numbers until FY15 and returns have been calculated from 31
December 2015 to 31 December 2016. (Note: The above exhibit only considers the share price returns and not
the total shareholder returns).
Note that this back-test does not consider accounting or management quality, which
we believe are factors that should improve the performance of our live portfolios.
That’s what the next section of this note focuses on.
Before we delve into this year’s list of 30 firms that constitute our ten baggers 6.0, the
following two exhibits show the performance of the live ten-baggers portfolio since
January 2012 when we first unveiled this framework. Whilst the BSE500 ten baggers
have managed to outperform the BSE500 Index by ~10% points per annum (on a
cumulative basis) over the last five years, the ten baggers from the sub-BSE500
universe that we highlighted in the previous four iterations have managed to
outperform the BSE Small-cap Index by a whopping 31% points per annum (on a
cumulative basis). Outperformance for all our live ten-baggers from the BSE500 and
the sub-BSE500 universe demonstrates that the construct works in the real world too.
Exhibit 7: Performance of the BSE500 ten-bagger portfolios (since 19 January 2012)
80.0
70.0
57.1
60.0 51.7
50.0 42.8
Return (%)
40.0
30.0
20.0 9.5
6.7
10.0 The live performance of our
- ten-bagger portfolios has been
(10.0) 2012 2013 2014 2015 2016 impressive too
Source: Bloomberg, Ambit Capital research. Note: Performance in exhibit 7 above is on a total-return basis; i.e.
assuming that dividends are reinvested back into the same stock on the ex-dividend date.
103.5
100.0
Return (%)
41.5
50.0
-
2013 2014 2015 2016
(50.0)
Small-caps tenbagger iteration return BSE Smallcap index return cumulative alpha
Source: Bloomberg, Ambit Capital research. Note: Performance in exhibit 8 above is on a total-return basis; i.e.
assuming that dividends are reinvested back into the same stock on the ex-dividend date.
To identify replacements for the stocks that get eliminated in the process, we start
with firms with the highest ‘greatness score’. Within these firms, we remove firms:
That fall in the ‘Zone of Darkness’ in our accounting model (i.e. the bottom 3
deciles on accounting quality; for a full exposition of our accounting filter, please
refer to our 16th December 2016 note);
Firms with suspect corporate governance; and
Firms with structural issues around the underlying business (e.g., new, well-
capitalised competitors have entered the market or adverse regulatory changes
has taken place).
This overlay of ‘greatness’, ‘accounting’, corporate governance and subjective checks
allows us to identify the 30 firms that comprise our ten-baggers portfolio.
There are 9 changes (implying 30% churn) with respect to last year’s list (refer to our
5th January 2016 note). A summary of these changes is as follows:
Exits: Sundaram Fasteners, Tata Motors and Supreme Industries drop out on
account of deterioration in their greatness scores whilst Lupin and TVS Motor
drop out on account of deterioration in their accounting scores. We also exclude
Mindtree, Idea Cellular, GSK Consumer and Persistent Systems on account of our
sector analysts’ structural SELLs on these firms.
Exhibit 9: Reasons behind the stocks exiting our ten-bagger portfolio
Company name Reasons for exclusion
Marginally misses the ‘greatness’ cut-off; gets a low score on investment in Gross Block and Sales improvement on
Sundaram Fasteners
the 'greatness' model
Tata Motors* Low score on pricing discipline and improvement in return ratios on the 'greatness' model
Supreme Industries* Low score on pricing discipline, improvement in return ratios and cash flows improvement on the 'greatness' model
Lupin* Features in 'D9' on accounting in our accounting model
TVS Motor Company Features in 'D8' on accounting in our accounting model
Mindtree Senior management attrition worries us
Likely to generate negative FCF over FY16-20 with RoCE remaining in low single digits. No sanctity of valuations at
Idea Cellular
5x EV/EBITDA.
GSK Consumer Inability to drive volume growth despite low category penetration
Persistent Systems Lacks winning ingredients to win in the next stage of digital
Source: Ace Equity, Capitaline, Ambit Capital research. Note: * We have a Bottom-up ‘BUY’ on these stocks
Having identified the 30 great firms that exhibit the ingredients required to be
tomorrow’s winners, we run a valuation check to ascertain if they are currently
trading at reasonable prices for outright investments. In our view, whilst valuations do
matter on a tactical basis, how the underlying fundamentals evolve for the firm over
long periods plays a more important role in determining returns than the beginning-
of-the-period valuation itself. Further, the performance of the previous iterations of
our ten-bagger portfolio corroborates our finding that beginning of the period
valuations do not play a significant role in shaping subsequent investment
returns. We discuss this in detail in the final section of this note.
To determine whether a particular stock is cheap or not, we categorise these stocks
into three buckets based on their relative attractiveness on valuations with respect to
their own history. We compare these firms with respect to their five-year average
valuations on three metrics—P/B, P/E and EV/EBITDA. We find nine firms to be
inexpensive (on at least two of the three metrics): TCS, ITC, HCL Tech, Gujarat For the long-term investor,
Pipavav Port, Britannia Industries, Pidilite Industries, Torrent Pharma, Mahindra CIE beginning-of-period valuations
and Tata Elxsi. However, for the long term, all 30 stocks remain candidates to be ten do not have a significant impact
baggers from our perspective (as we have reiterated time and again that current on returns
period valuations do not have a significant effect on long-term returns! Please see
pages 18-19 for details).
We have bottom-up coverage with BUYs on 13 of these names. These are: TCS, ITC,
HCL Technologies, Pidilite Industries, Torrent Pharma, Mahindra CIE, HUL, Page
Industries, AIA Engineering, PI Industries, Finolex Cables, Hatsun Agro Products and
Vinati Organics.
Exhibit 12: January 2017 ten baggers - Forward-looking data using consensus estimates
Mcap 6M ADV FY16-FY19E FY16-FY19E
Ticker Company
US$ mn) (US$ mn) EPS CAGR BPS CAGR
Attractive valuations*
TCS IN TCS 67,681 44.1 9% 16%
ITC IN ITC 44,009 37.4 12% 15%
HCLT IN HCL Technologies 17,538 21.4 10% 14%
GPPV IN Guj Pipavav Port 941 1.8 18% 6%
BRIT IN Britannia Industries 5,060 8.7 17% 26%
PIDI IN Pidilite Industries 4,614 5.5 14% 19%
TRP IN Torrent Pharma. 3,380 4.5 20%^ 22%
MACA IN Mahindra CIE 1,044 0.6 19% 20%
TELX IN Tata Elxsi 657 9.1 18% 25%
Moderate valuations**
HUVR IN Hind. Unilever 26,532 16.5 12% 2%
PAG IN Page Industries 2,262 2.5 23% 27%
VTEX IN Vardhman Textile 1,039 0.9 13% 14%
Rich valuations***
EIM IN Eicher Motors 8,936 18.9 35% 33%
MRCO IN Marico 4,947 5.4 15% 14%
MRF IN MRF 3,227 11.6 12% 24%
BRGR IN Berger Paints 3,057 2.4 22% 17%
AJP IN Ajanta Pharma 2,317 4.1 23% 33%
AIAE IN AIA Engineering 1,796 1.1 13% 16%
PI IN P I Industries 1,692 1.3 21% 25%
KJC IN Kajaria Ceramics 1,158 1.6 17% 21%
FNXC IN Finolex Cables 936 0.5 13% 12%
ATLP IN Atul# 894 1.7 16% 21%
ARTO IN Aarti Industries# 847 0.6 23% 24%
HTSMF IN Hatsun AgroProd.# 819 0.1 38% 24%
RLXF IN Relaxo Footwear# 707 0.1 28% 24%
JCHAC IN Johnson Con. Hit 553 0.4 43% 25%
VO IN Vinati Organics 476 0.4 14% 21%
LOG IN La Opala RG 377 0.3 17% 22%
SRTY IN TVS Srichakra# 369 0.7 1% 28%
AVNT IN Avanti Feeds# 340 0.3 N/A N/A
Source: Bloomberg, Ambit Capital research; Note: # indicates FY16-18E CAGR. ^ Torrent Pharma reported limited competition one-off revenues from sale of
generic Abilify in FY16. Hence EPS CAGR has been calculated over FY17E-19E.
* Trading below five-year average P/E, P/B, EV/EBITDA (on at least two of these three measures)
** Trading below either five-year average P/E, five-year P/B or five-year EV/EBITDA (on one of these three measures)
*** Trading above five-year average P/E, P/B and EV/EBITDA
Note that unlike the ten-baggers list for the BSE500 universe (where we only consider
firms that meet the greatness score cut-off of 67% whilst being in the top 7 deciles of
our forensic accounting model), the criteria used to screen for ten baggers from the
sub-BSE500 universe has been made much more stringent. Only firms with a
greatness score above 80% that also fall in the top three deciles on accounting
quality in the sub-BSE500 universe have been included in this list.
On a separate note, in the wake of several clients requesting access to both our
‘forensic’ and ‘greatness’ models, in July last year, we launched our ‘HAWK’ platform
giving clients access to Ambit’s proprietary ‘forensic’ and ‘greatness’ models in an
easy to use and intuitive format (click here for the User Guide). Our ‘HAWK’ platform
allows clients to screen the entire universe ex-financials (~1,300 listed Indian
companies) on the basis of their accounting quality (quantified using our ‘forensic’
model) and capital allocation track record (quantified using our ‘greatness’
framework’) over the last 10 years. Whilst the platform currently has the accounting
scores for all the companies updated until FY15, in a couple of weeks from now, we
will refresh our platform to incorporate FY16 financials as well.
Please contact your relevant sales representatives at Ambit if you have not yet
received the login credentials for ‘HAWK’ or if you would like a demo on how to use
the product.
Whilst the broader markets (read BSE500 index) have delivered 8.5% total returns last
year, the last year’s iteration of ten baggers portfolio published on 05 January 2016
managed to clock 13.9% returns in absolute terms (thus implying 5.4% points alpha
relative to the BSE500). This compares with cumulative absolute returns of 121% and
relative returns (to BSE500) of 52% points delivered by the first four iterations
(click here for the 19 January 2012 note on ten baggers 1.0; click here for the 14
January 2013 note on ten baggers 2.0; click here for the 26 November 2013 note on
ten bagger 3.0 and click here for the 05 January 2015 note on ten bagger 4.0).
Moreover, the above exhibit also highlights that beginning-of-the-period valuations
have not made much difference to investment returns, with the stocks categorised as
attractively valued, based on initial valuations, underperforming those classified as
richly valued on average. This finding also emerged from earlier ten bagger
iterations. In effect, what our models have shown time and again is that once you
screen rigorously for high quality, there is little value-add in further
screening through a demanding valuation filter.
40% R² = 0.0536
FY06-FY16 share price CAGR
30%
20%
(rel. to sensex)
10%
0%
-10% - 10.0 20.0 30.0 40.0 50.0 60.0
-20%
-30%
-40%
-50%
FY06 Price to Book ratio
Source: Ambit Capital research; Note: FY06-16 returns here are stock returns relative to Sensex
The value of the R-squared makes the story self-explanatory. A low value for this
parameter indicates that the beginning-period valuations do not play any meaningful
role in explaining stock returns over the next ten years. This holds true for both P/B
and P/E as measures of valuation.
Exhibit 17: Valuation impact on long-term returns - P/E
40% R² = 0.0228
FY06-FY16 share price CAGR
30%
20%
(rel. to sensex)
10%
0%
-10% - 20.0 40.0 60.0 80.0 100.0 120.0
-20%
-30%
-40%
-50%
FY06 Price to Earnings ratio
Source: Ambit Capital research; Note: FY06-16 returns here are stock returns relative to Sensex. Trailing P/E has
been restricted to 100.
Exhibit 18: Ten baggers 5.0 - Beginning-period P/B and stock returns
100%
Share price performance
80% R² = 0.0416
60%
40%
20%
0%
-20% - 10.0 20.0 30.0 40.0 50.0
-40%
-60%
Here again, a low R-squared value indicates that the beginning-period P/B does not
influence stock returns to a significant extent. This holds true for P/E as a measure of
valuation as well.
Exhibit 19: Ten baggers 5.0: beginning-period P/E and stock returns
100%
Share price performance
80%
R² = 0.019
60%
40%
20%
0%
- 20.0 40.0 60.0 80.0 100.0 120.0
-20%
-40%
-60%
Tata Consultancy Svcs Ltd (TCS IN, BUY) ITC Ltd (ITC IN, BUY)
3,000 280
2,500 260
2,000 240
220
1,500
200
1,000 180
500 160
0 140
Sep-14
Sep-15
Sep-16
Dec-13
Mar-14
Jun-14
Dec-14
Mar-15
Jun-15
Dec-15
Mar-16
Jun-16
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Jun-14
Jun-15
Jun-16
Tata Consultancy Services Ltd ITC Ltd
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
HCL Technologies Ltd (HCLT IN, BUY) Gujarat Pipavav Port Ltd (GPPV IN, NOT RATED)
1,200 300
1,000 250
800 200
600 150
400 100
200 50
0 0
Dec-13
Sep-14
Dec-14
Sep-15
Dec-15
Sep-16
Dec-13
Sep-14
Dec-14
Sep-15
Dec-15
Sep-16
Mar-14
Jun-14
Mar-15
Jun-15
Mar-16
Jun-16
Mar-14
Jun-14
Mar-15
Jun-15
Mar-16
Jun-16
HCL Technologies Ltd Gujarat Pipavav Port Ltd
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
Britannia Industries Ltd (BRIT IN, SELL) Pidilite Industries Ltd (PIDI IN, BUY)
4,000 800
3,500 700
3,000 600
2,500 500
2,000 400
1,500 300
1,000 200
500 100
0 0
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Jun-14
Jun-15
Jun-16
Jun-14
Jun-15
Jun-16
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
Torrent Pharmaceuticals Ltd (TRP IN, BUY) Mahindra CIE Automotive (MACA IN, BUY)
1,800 350
1,600 300
1,400
1,200 250
1,000 200
800 150
600 100
400
200 50
0 0
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-13
Sep-14
Dec-14
Sep-15
Dec-15
Sep-16
Jun-14
Jun-15
Jun-16
Mar-14
Jun-14
Mar-15
Jun-15
Mar-16
Jun-16
Torrent Pharmaceuticals Ltd Mahindra CIE Automotive Ltd
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
Hindustan Unilever Ltd (HUVR IN, BUY) Page Industries Ltd (PAG IN, NOT RATED)
1,200 18,000
16,000
1,000
14,000
800 12,000
10,000
600
8,000
400 6,000
4,000
200
2,000
0 0
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Jun-14
Jun-15
Jun-16
Jun-14
Jun-15
Jun-16
Hindustan Unilever Ltd Page Industries Ltd
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
Eicher Motors Ltd (EIM IN, SELL) Marico Ltd (MRCO IN, SELL)
30,000 350
25,000 300
250
20,000
200
15,000
150
10,000
100
5,000 50
0 0
Dec-13
Sep-14
Dec-14
Sep-15
Dec-15
Sep-16
Dec-13
Sep-14
Dec-14
Sep-15
Dec-15
Sep-16
Mar-14
Jun-14
Mar-15
Jun-15
Mar-16
Jun-16
Mar-14
Jun-14
Mar-15
Jun-15
Mar-16
Jun-16
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
MRF Ltd (MRF IN, NOT RATED) Berger Paints India Ltd (BRGR IN, SELL)
60,000 300
50,000 250
40,000 200
30,000 150
20,000 100
10,000 50
0 0
Dec-13
Sep-14
Dec-14
Sep-15
Dec-15
Sep-16
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Mar-14
Jun-14
Mar-15
Jun-15
Mar-16
Jun-16
Jun-14
Jun-15
Jun-16
MRF Ltd Berger Paints India Ltd
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
PI Industries Ltd (PI IN, BUY) AIA Engineering Ltd (AIAE IN, BUY)
1,000 1,600
1,400
800
1,200
600 1,000
800
400 600
400
200
200
0 0
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Jun-14
Jun-15
Jun-16
Jun-14
Jun-15
Jun-16
PI Industries Ltd AIA Engineering Ltd
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
Kajaria Ceramics Ltd (KJC IN, NOT RATED) Finolex Cables Ltd (FNXC IN, BUY)
800 500
700
400
600
500 300
400
300 200
200
100
100
0 0
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Jun-14
Jun-15
Jun-16
Jun-14
Jun-15
Jun-16
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
Tata Elxsi Ltd (TELX IN, NOT RATED) Vardhman Textiles Ltd (VTEX IN, NOT RATED)
2,500 1,400
1,200
2,000
1,000
1,500 800
1,000 600
400
500
200
0 0
Jan-14
Apr-14
Jul-14
Oct-14
Jan-15
Apr-15
Jul-15
Oct-15
Jan-16
Apr-16
Jul-16
Oct-16
Jan-14
Apr-14
Jul-14
Oct-14
Jan-15
Apr-15
Jul-15
Oct-15
Jan-16
Apr-16
Jul-16
Oct-16
Tata Elxsi Ltd Vardhman Textiles Ltd
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
Ajanta Pharma Ltd (AJP IN, NOT RATED) Atul Ltd (ATLP IN IN, NOT RATED)
2,500 3,000
2,000 2,500
2,000
1,500
1,500
1,000
1,000
500 500
0 0
Apr-14
Apr-15
Apr-16
Apr-14
Apr-15
Apr-16
Jan-14
Jul-14
Oct-14
Jan-15
Jul-15
Oct-15
Jan-16
Jul-16
Oct-16
Jan-14
Jul-14
Oct-14
Jan-15
Jul-15
Oct-15
Jan-16
Jul-16
Oct-16
Ajanta Pharma Ltd Atul Ltd
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
Aarti Industries (ARTO IN, NOT RATED) Relaxo Footwears Ltd (RLXF IN, NOT RATED)
800 700
700 600
600 500
500
400
400
300
300
200 200
100 100
0 0
Jan-14
Apr-14
Jul-14
Oct-14
Jan-15
Apr-15
Jul-15
Oct-15
Jan-16
Apr-16
Jul-16
Oct-16
Jan-14
Apr-14
Jul-14
Oct-14
Jan-15
Apr-15
Jul-15
Oct-15
Jan-16
Apr-16
Jul-16
Oct-16
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
Johnson Controls-Hitachi Air Conditioning India Ltd LA Opala RG Ltd (LOG IN, NOT RATED)
(JCHAC IN, NOT RATED)
2,000 700
600
1,500
500
1,000 400
300
500 200
0 100
Jan-14
Apr-14
Jul-14
Oct-14
Jan-15
Apr-15
Jul-15
Oct-15
Jan-16
Apr-16
Jul-16
Oct-16
0
Jan-14
Apr-14
Jul-14
Jan-15
Apr-15
Jul-15
Jan-16
Apr-16
Jul-16
Oct-14
Oct-15
Oct-16
Johnson Controls-Hitachi Air Conditioning India
Ltd LA Opala RG Ltd
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
TVS Srichakra Ltd (SRTY IN, NOT RATED) Avanti Feeds Ltd (AVNT IN, NOT RATED)
4,500 800
4,000 700
3,500 600
3,000 500
2,500
400
2,000
1,500 300
1,000 200
500 100
0 0
Jan-14
Apr-14
Jul-14
Oct-14
Jan-15
Apr-15
Jul-15
Oct-15
Jan-16
Apr-16
Jul-16
Oct-16
Jan-14
Apr-14
Jul-14
Oct-14
Jan-15
Apr-15
Jul-15
Oct-15
Jan-16
Apr-16
Jul-16
Oct-16
TVS Srichakra Ltd Avanti Feeds Ltd
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
Igarashi Motors India Ltd (IGM IN, NOT RATED) Accelya Kale Solutions Ltd (KALE IN, NOT RATED)
900 1,600
800 1,400
700 1,200
600 1,000
500
800
400
300 600
200 400
100 200
0 0
Jan-14
Apr-14
Jul-14
Oct-14
Jan-15
Apr-15
Jul-15
Oct-15
Jan-16
Apr-16
Jul-16
Oct-16
Jan-14
Apr-14
Jul-14
Oct-14
Jan-15
Apr-15
Jul-15
Oct-15
Jan-16
Apr-16
Jul-16
Oct-16
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
FIEM Industries Ltd (FIEM IN, NOT RATED) RSWM Ltd (RJS IN, NOT RATED)
1,600 600
1,400 500
1,200
1,000 400
800 300
600 200
400
200 100
0 0
Jan-14
Apr-14
Jul-14
Oct-14
Jan-15
Apr-15
Jul-15
Oct-15
Jan-16
Apr-16
Jul-16
Oct-16
Jan-14
Apr-14
Jul-14
Oct-14
Jan-15
Apr-15
Jul-15
Oct-15
Jan-16
Apr-16
Jul-16
Oct-16
FIEM Industries Ltd RSWM Ltd
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
Atul Auto Ltd (ATA IN, NOT RATED) Alkyl Amines Chemicals (AACL IN, NOT RATED)
800 450
700 400
600 350
500 300
250
400
200
300 150
200 100
100 50
0 0
Apr-14
Apr-15
Apr-16
Apr-14
Apr-15
Apr-16
Jan-14
Jul-14
Oct-14
Jan-15
Jul-15
Oct-15
Jan-16
Jul-16
Oct-16
Jan-14
Jul-14
Oct-14
Jan-15
Jul-15
Oct-15
Jan-16
Jul-16
Oct-16
Atul Auto Ltd Alkyl Amines Chemicals
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
TCPL Packaging Ltd (TCPL IN, NOT RATED) Multibase India Ltd (MUIL IN, NOT RATED)
900 350
800 300
700
600 250
500 200
400 150
300
100
200
100 50
0 0
Jan-14
Apr-14
Jul-14
Oct-14
Jan-15
Apr-15
Jul-15
Oct-15
Jan-16
Apr-16
Jul-16
Oct-16
Jan-14
Apr-14
Jul-14
Oct-14
Jan-15
Apr-15
Jul-15
Oct-15
Jan-16
Apr-16
Jul-16
Oct-16
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
Excel Crop Care Ltd (EXCC IN, NOT RATED) WIM Plast Ltd (WMP IN, NOT RATED)
2,500 1,800
1,600
2,000 1,400
1,200
1,500 1,000
1,000 800
600
500 400
200
0 0
Jan-14
Apr-14
Jul-14
Oct-14
Jan-15
Apr-15
Jul-15
Oct-15
Jan-16
Apr-16
Jul-16
Oct-16
Jan-14
Apr-14
Jul-14
Oct-14
Jan-15
Apr-15
Jul-15
Oct-15
Jan-16
Apr-16
Jul-16
Oct-16
Excel Crop Care Ltd WIM Plast Ltd
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
GMM Pfaudler Ltd (GMM IN, NOT RATED) Hatsun Agro Products Ltd (HTSMF IN, BUY)
700 400
600 350
500 300
250
400
200
300
150
200 100
100 50
0 0
Apr-14
Apr-15
Apr-16
Jan-14
Jul-14
Oct-14
Jan-15
Jul-15
Oct-15
Jan-16
Jul-16
Oct-16
Jan-14
Apr-14
Jul-14
Oct-14
Jan-15
Apr-15
Jul-15
Oct-15
Jan-16
Apr-16
Jul-16
Oct-16
GMM Pfaudler Ltd Hatsun Agro Products Ltd
Source: Bloomberg, Ambit Capital research Source: Bloomberg, Ambit Capital research
700
600
500
400
300
200
100
0
Jan-14
Apr-14
Jul-14
Oct-14
Jan-15
Apr-15
Jul-15
Oct-15
Jan-16
Apr-16
Jul-16
Oct-16
Disclaimer
1. AMBIT Capital Private Limited (“AMBIT Capital”) and its affiliates are a full service, integrated investment banking, investment advisory and brokerage group. AMBIT Capital is a Stock Broker, Portfolio
Manager and Depository Participant registered with Securities and Exchange Board of India Limited (SEBI) and is regulated by SEBI.
2. AMBIT Capital makes best endeavours to ensure that the research analyst(s) use current, reliable, comprehensive information and obtain such information from sources which the analyst(s) believes
to be reliable. However, such information has not been independently verified by AMBIT Capital and/or the analyst(s) and no representation or warranty, express or implied, is made as to the
accuracy or completeness of any information obtained from third parties. The information, opinions, views expressed in this Research Report are those of the research analyst as at the date of this
Research Report which are subject to change and do not represent to be an authority on the subject. AMBIT Capital may or may not subscribe to any and/ or all the views expressed herein.
3. This Research Report should be read and relied upon at the sole discretion and risk of the recipient. If you are dissatisfied with the contents of this complimentary Research Report or with the terms of
this Disclaimer, your sole and exclusive remedy is to stop using this Research Report and AMBIT Capital or its affiliates shall not be responsible and/ or liable for any direct/consequential loss
howsoever directly or indirectly, from any use of this Research Report.
4. If this Research Report is received by any client of AMBIT Capital or its affiliate, the relationship of AMBIT Capital/its affiliate with such client will continue to be governed by the terms and conditions
in place between AMBIT Capital/ such affiliate and the client.
5. This Research Report is issued for information only and the 'Buy', 'Sell', or ‘Other Recommendation’ made in this Research Report such should not be construed as an investment advice to any
recipient to acquire, subscribe, purchase, sell, dispose of, retain any securities and should not be intended or treated as a substitute for necessary review or validation or any professional advice.
Recipients should consider this Research Report as only a single factor in making any investment decisions. This Research Report is not an offer to sell or the solicitation of an offer to purchase or
subscribe for any investment or as an official endorsement of any investment.
6. This Research Report is being supplied to you solely for your information and may not be reproduced, redistributed or passed on, directly or indirectly, to any other person or published, copied in
whole or in part, for any purpose. Neither this Research Report nor any copy of it may be taken or transmitted or distributed, directly or indirectly within India or into any other country including
United States (to US Persons), Canada or Japan or to any resident thereof. The distribution of this Research Report in other jurisdictions may be strictly restricted and/ or prohibited by law or contract,
and persons into whose possession this Research Report comes should inform themselves about such restriction and/ or prohibition, and observe any such restrictions and/ or prohibition.
7. Ambit Capital Private Limited is registered as a Research Entity under the SEBI (Research Analysts) Regulations, 2014. SEBI Reg.No.- INH000000313.
Conflict of Interests
8. In the normal course of AMBIT Capital’s business circumstances may arise that could result in the interests of AMBIT Capital conflicting with the interests of clients or one client’s interests conflicting
with the interest of another client. AMBIT Capital makes best efforts to ensure that conflicts are identified and managed and that clients’ interests are protected. AMBIT Capital has policies and
procedures in place to control the flow and use of non-public, price sensitive information and employees’ personal account trading. Where appropriate and reasonably achievable, AMBIT Capital
segregates the activities of staff working in areas where conflicts of interest may arise. However, clients/potential clients of AMBIT Capital should be aware of these possible conflicts of interests and
should make informed decisions in relation to AMBIT Capital’s services.
9. AMBIT Capital and/or its affiliates may from time to time have or solicit investment banking, investment advisory and other business relationships with companies covered in this Research Report and
may receive compensation for the same.
25. The value of any investment made at your discretion based on this Report, or income therefrom, maybe affected by changes in economic, financial and/or political factors and may go down as well
as go up and you may not get back the original amount invested. Some securities and/or investments involve substantial risk and are not suitable for all investors.
26. Ambit and its affiliates and their respective officers directors and employees may hold positions in any securities mentioned in this Report (or in any related investment) and may from time to time add
to or dispose of any such securities (or investment). Ambit and ACUK may from time to time render advisory and other services to companies referred to in this Report and may receive compensation
for the same.
27. Ambit and its affiliates may act as a market maker or risk arbitrator or liquidity provider or may have assumed an underwriting commitment in the securities of companies discussed in this Report (or
in related investments) or may sell them or buy them from clients on a principal to principal basis or may be involved in proprietary trading and may also perform or seek to perform investment
banking or underwriting services for or relating to those companies.
28. Ambit and ACUK may sell or buy any securities or make any investment which may be contrary to or inconsistent with this Report and are not subject to any prohibition on dealing. By accepting this
report you agree to be bound by the foregoing limitations. In the normal course of Ambit and its affiliates’ business, circumstances may arise that could result in the interests of Ambit conflicting with
the interests of clients or one client’s interests conflicting with the interest of another client. Ambit makes best efforts to ensure that conflicts are identified, managed and clients’ interests are
protected. However, clients/potential clients of Ambit should be aware of these possible conflicts of interests and should make informed decisions in relation to Ambit services.
Disclosures
29. The analyst (s) has/have not served as an officer, director or employee of the subject company.
30. There is no material disciplinary action that has been taken by any regulatory authority impacting equity research analysis activities.
31. All market data included in this report are dated as at the previous stock market closing day from the date of this report.
Analyst Certification
Each of the analysts identified in this report certifies, with respect to the companies or securities that the individual analyses, that (1) the views expressed in this report reflect his or her personal views
about all of the subject companies and securities and (2) no part of his or her compensation was, is or will be directly or indirectly dependent on the specific recommendations or views expressed in this
report.